Expert Pitch

New National Poll: American’s Trust In Leaders and Institutions Declines During COVID-19 Pandemic

Rutgers scholar Katherine Ognyanova is available to comment on the latest survey data from The COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States, a joint project of Rutgers, Northeastern, Harvard, and Northwestern.

The researchers polled participants on whether they trust certain institutions and people to do the right thing to handle the coronavirus outbreak. Fifteen leaders and organizations included city governments, state governments, White House, Congress, Donald Trump, Joe Biden, Anthony Fauci, doctors and hospitals, pharmaceutical companies, scientists and researchers, police, banks, news media and social media companies. The survey also charts how U.S. public opinion has changed since late April.

To view the full report and findings, click here. Among the findings:

  • The White House and Congress saw the biggest decline in trust from 59% to 46% and from 55% to 42%, respectively, between late April and August.
  • Trust in President Trump to manage the COVID-19 crisis declined from 50% to 43%.
  • Levels of trust were lower in August than April for every institution and individual tracked, with the smallest decline being for Joe Biden, whose trust level fell from 51% to 50%.
  • Republicans expressed higher levels of trust in the police than Democrats or independents, with all three maintaining steady levels from July to August (83% in both cases for Republicans; from 56% to 57% for Democrats, and from 59% to 60% for independents).
  • Scientists and medical experts have the highest levels of public trust. Public trust in hospitals and doctors, as well as for scientists and researchers, have all remained at high levels (more than 85%) from April to August.
  • Among people who will get a COVID-19 vaccine, figures vary from a low of 53% for people who trust President Trump’s management of the COVID-19 crisis to a high of 71% among respondents who indicate trust in Joe Biden.
  • 68% of people who trust Fauci intend to get a COVID-19 vaccine, as did 70% who trust the news media, 68% who trust social media platforms.

Katherine Ognyanova, an assistant professor at Rutgers’ School of Communication and Information, does research in network science, computational social science, social technology, media, civic and political communication.

The researchers surveyed 21,196 people across all 50 states plus the District of Columbia from Aug. 7 – 26.

For interviews, contact Megan Schumann, [email protected], 848-445-1907

###

Broadcast interviews: Rutgers University–New Brunswick has broadcast-quality TV and radio studios available for remote live or taped interviews with Rutgers experts. For more information, contact Neal Buccino [email protected]

ABOUT RUTGERS—NEW BRUNSWICK

Rutgers University–New Brunswick is where Rutgers, the State University of New Jersey, began more than 250 years ago. Ranked among the world’s top 60 universities, Rutgers’s flagship university is a leading public research institution and a member of the prestigious Association of American Universities. It is home to internationally acclaimed faculty and has 12 degree-granting schools and a Division I Athletics program. It is the Big Ten Conference’s most diverse university. Through its community of teachers, scholars, artists, scientists, and healers, Rutgers is equipped as never before to transform lives.

 



Filters close

Showing results

110 of 6110
Released: 2-Aug-2021 6:05 PM EDT
Rethinking Remdesivir
University of California San Diego Health

UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.

Newswise: Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Released: 2-Aug-2021 4:25 PM EDT
Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Hackensack Meridian Health

New COVID-19 40-day mortality risk model, published in The Public Library of Science ONE, has potential for use in patient treatment planning, comparisons of therapeutic strategies, and public-health preparations.

Released: 2-Aug-2021 4:05 PM EDT
Town Hall on Effectiveness of COVID-19 Vaccination in Immunosuppressed Patients Hosted by the American College of Rheumatology
American College of Rheumatology (ACR)

How effective COVID-19 vaccines have been in immunosuppressed and rheumatic disease patients remains an incompletely answered question. The American College of Rheumatology (ACR) has organized an expert panel to share what we are learning from real-world data and answer questions.

Released: 2-Aug-2021 2:00 PM EDT
CDC withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test does not mean the test failed
Newswise

Social media is now rife with claims about why the CDC is withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test after December 2021.

Newswise: Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Released: 2-Aug-2021 1:30 PM EDT
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Argonne National Laboratory

Scientists using the Advanced Photon Source have discovered that a drug used to fight tumors in animals might be effective against many types of coronaviruses, including SARS-CoV-2.

Released: 2-Aug-2021 11:25 AM EDT
Award-Winning Journalist and CDC Principal Investigator to Serve as ACR Convergence 2021 Keynote Speaker
American College of Rheumatology (ACR)

Convergence 2021, the annual meeting of the American College of Rheumatology (ACR), returns to a virtual meeting platform Nov. 1 - 10. This year’s meeting will include presentations from over 320 clinicians, researchers and health experts, including this year’s keynote speaker, Dr. Seema Yasmin.

Newswise: COVID-19: Small Sign of Hope as Vaccinations Rise
Released: 2-Aug-2021 10:45 AM EDT
COVID-19: Small Sign of Hope as Vaccinations Rise
Cedars-Sinai

As COVID-19 cases spike in Los Angeles and throughout the Golden State, driven by the spread of the delta variant among unvaccinated residents, there may be a small sign of hope: More people are finally getting their shot.

Newswise: New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
Released: 31-Jul-2021 10:05 AM EDT
New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
University of Miami Health System, Miller School of Medicine

The University’s coronavirus sequencing effort uncovered that there are several variants present in its patient population, but Delta is chief among them and easily transmitted. And its presence is likely triggering a local surge in the infectious disease. University of Miami researchers and physicians are seeing firsthand how rapidly the Delta variant of COVID-19 is spreading through the local population.

Released: 30-Jul-2021 2:05 PM EDT
Thinking Impaired in 60% of COVID-19 Survivors, Study Finds
University of Texas Health Science Center at San Antonio

In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San Antonio reported July 29 at the Alzheimer’s Association International Conference.


Showing results

110 of 6110

close
24.58665